Cytokinetics

Associate Director, Quality Compliance

South San Francisco, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalIndustries

Requirements

A minimum of a bachelor's degree in a scientific field or equivalent is required. Candidates must possess over 10 years of experience in Quality Compliance within the biopharmaceutical, pharmaceutical, biologics, or related life sciences sector. Strong experience in performing supplier audits, including GMP manufacturing, laboratories, warehouse and distribution, validation, and computerized systems, is essential.

Responsibilities

The Associate Director of Quality Compliance will optimize and ensure the execution of quality processes and systems, collaborating with cross-functional teams to support GMP development and commercial launch activities. This role involves leading various aspects of Cytokinetics Quality Compliance, maintaining an effective function to ensure adherence to GMP/GDP regulations, and overseeing the GMP supplier quality program, including evaluations, risk assessments, qualifications, audits, and quality agreements. Responsibilities also include leading GMP/GDP and GxP computerized system supplier audits, ensuring quality agreement negotiations meet expectations and comply with regulations, maintaining supplier quality records, and advising management on regulatory surveillance. Additionally, the position supports inspection readiness for anticipated regulatory inspections and partner audits, monitors CMOs and contract labs for inspection status, and provides support for cross-functional teams and training. The role involves supporting the Quality Risk Management program, establishing and improving policies and systems for GMP activities oversight, providing technical support for investigations and training, developing and interpreting program metrics, representing Quality in cross-functional teams, and staying current with GxP regulations, providing impact assessments and recommendations for new requirements.

Skills

Quality Compliance
GMP
GDP
GxP
Supplier Quality
Audits
Risk Assessment
Quality Agreements
Computerized Systems
Biopharmaceutical

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI